News
Kennedy and advocates have very different views on how his tenure impacts the community of Americans with disabilities.
FDA permits use of Sarepta Therapeutics’ Duchenne therapy in younger patients after short-lived halt
The FDA said it was clearing the way for Sarepta Therapeutics to resume shipments of its gene therapy for Duchenne muscular ...
WASHINGTON — President Trump’s tariffs on pharmaceuticals coming from the European Union will be set at 15% and will not go ...
There are nearly 11 million people in America who are older and extremely destitute — to the point where they qualify for a ...
A federal judge on Monday ruled Planned Parenthood clinics nationwide must continue to be reimbursed for Medicaid funding as ...
A major medical group is pushing back after a report that RFK Jr. plans to fire members of a key preventive care panel.
And more biotech news brought to you by The Readout.
When Jeff Vierstra (above) signed up for Columbia University’s ALS Families Project, he thought he would be participating as ...
The FDA has recently held a slew of so-called "expert panels" that sidestep legal procedures and ethics guardrails ...
GSK is paying $500M upfront for rights to a series of Hengrui drugs, the latest case of a pharma company looking to a Chinese firm to build out its pipeline.
Initial analyses of the Trump administration’s proposed NIH cuts neglect key aspects of their long-term economic and health ...
For over an hour, Jeff Vierstra lay still in Columbia University’s ALS clinic, as a doctor poked him ankle-to-throat with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results